A first group (50% of Richter syndrome) bears TP53 inactivation (by loss or by somatic mutations) and/or CDKN2A loss, alongside MYC gain/amplifications, 13q14.3 loss and additional lesions (33). Here, CDKN2A is linked to Richter syndrome.